Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Ravaud

Showing results (81-90 of 221) with videos related to

Pageof 23
Sort By:
Cancers|February 25, 2023
Combinations of Anti-Angiogenic Agents and Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Best Option?Estelle Granet-Vaissiere, Félix Lefort, Charlotte Domblides, et al.
BMJ Oncology|December 1, 2025
Evidence-based modelling and taxonomy of hospital-based cancer care coordination nurses' roles and boundaries: an iterative multiphase convergent mixed studyFrançoise Colombani, Nicolas Calcagni, Matthieu Sibé, et al.
Cancer Management and Research|October 16, 2020
Management of Immune Checkpoint Inhibitor ToxicitiesQuentin Durrechou, Charlotte Domblides, Baptiste Sionneau, et al.
Cancer|November 19, 2002
Subcutaneous interleukin-2 and interferon alpha in the treatment of patients with metastatic renal cell carcinoma-Less efficacy compared with intravenous interleukin-2 and interferon alpha. Results of a multicenter Phase II trial from the Groupe Français d'ImmunothérapieAlain Ravaud, Rémy Delva, Fréderic Gomez, et al.
Oral Oncology|November 8, 2016
Immunotherapy in head and neck cancer: Need for a new strategy? Rapid progression with nivolumab then unexpected response with next treatmentAmaury Daste, Erwan de Mones, Laurence Digue, et al.
Thoracic Cancer|April 18, 2022
Effect of prior immunotherapy on the efficacy of chemotherapy in advanced non-small cell lung cancer: A retrospective studyLuc Heraudet, Tara Delon, Rémi Veillon, et al.
World Journal of Urology|April 2, 2013
The role of surgery for metastatic renal cell carcinoma in the era of targeted therapiesPierre Bigot, Souhil Lebdai, Alain Ravaud, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 28, 2019
Long-term prognosis of septic shock in cancer patientsFabrice Camou, Marion Didier, Thibaut Leguay, et al.
Frontiers in Surgery|June 26, 2020
Exploring Biological Predictive Factors of Progression After Surgery in High-Risk Renal Cell Carcinoma: Results From the French Cohort of the Randomized S-TRAC Trial PatientsIdir Ouzaid, Solène Florence Kammerer-Jacquet, Zineddine Khene, et al.
Urology|July 11, 2009
Laparoscopic radical prostatectomy in renal transplant recipientsGrégoire Robert, Hicham Elkentaoui, Gilles Pasticier, et al.
Pageof 23

Showing results (81-90 of 221) with videos related to

Sort By:
Pageof 23
Cancers|February 25, 2023
Combinations of Anti-Angiogenic Agents and Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Best Option?Estelle Granet-Vaissiere, Félix Lefort, Charlotte Domblides, et al.
BMJ Oncology|December 1, 2025
Evidence-based modelling and taxonomy of hospital-based cancer care coordination nurses' roles and boundaries: an iterative multiphase convergent mixed studyFrançoise Colombani, Nicolas Calcagni, Matthieu Sibé, et al.
Cancer Management and Research|October 16, 2020
Management of Immune Checkpoint Inhibitor ToxicitiesQuentin Durrechou, Charlotte Domblides, Baptiste Sionneau, et al.
Cancer|November 19, 2002
Subcutaneous interleukin-2 and interferon alpha in the treatment of patients with metastatic renal cell carcinoma-Less efficacy compared with intravenous interleukin-2 and interferon alpha. Results of a multicenter Phase II trial from the Groupe Français d'ImmunothérapieAlain Ravaud, Rémy Delva, Fréderic Gomez, et al.
Oral Oncology|November 8, 2016
Immunotherapy in head and neck cancer: Need for a new strategy? Rapid progression with nivolumab then unexpected response with next treatmentAmaury Daste, Erwan de Mones, Laurence Digue, et al.
Thoracic Cancer|April 18, 2022
Effect of prior immunotherapy on the efficacy of chemotherapy in advanced non-small cell lung cancer: A retrospective studyLuc Heraudet, Tara Delon, Rémi Veillon, et al.
World Journal of Urology|April 2, 2013
The role of surgery for metastatic renal cell carcinoma in the era of targeted therapiesPierre Bigot, Souhil Lebdai, Alain Ravaud, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 28, 2019
Long-term prognosis of septic shock in cancer patientsFabrice Camou, Marion Didier, Thibaut Leguay, et al.
Frontiers in Surgery|June 26, 2020
Exploring Biological Predictive Factors of Progression After Surgery in High-Risk Renal Cell Carcinoma: Results From the French Cohort of the Randomized S-TRAC Trial PatientsIdir Ouzaid, Solène Florence Kammerer-Jacquet, Zineddine Khene, et al.
Urology|July 11, 2009
Laparoscopic radical prostatectomy in renal transplant recipientsGrégoire Robert, Hicham Elkentaoui, Gilles Pasticier, et al.
Pageof 23